Skip to Content
Merck

5.08052

iMDK

≥98% (HPLC), solid, midkine inhibitor, Calbiochem®

Synonym(s):

Midkine Inhibitor, iMDK, 3-(2-(4-Fluorobenzyl)imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one, 3-(2-(4-Fluorobenzyl)imidazo[2,1-b][1,3]thiazol-6-yl)-2H-chromen-2-one, MDK Expression Inhibitor

Sign In to View Organizational & Contract Pricing.

Select a Size



About This Item

Empirical Formula (Hill Notation):
C21H13FN2O2S
CAS Number:
Molecular Weight:
376.40
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77
PubChem Substance ID:

Product Name

Midkine Inhibitor, iMDK,

InChI key

IWFKQTWYILKFGE-UHFFFAOYSA-N

SMILES string

C1=CC=C2C(=C1)C=C(C(=O)O2)C3=CN4C=C(SC4=N3)CC5=CC=C(C=C5)F

assay

≥98% (HPLC)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze
protect from light

color

off-white

solubility

DMSO: 5 mg/mL

storage temp.

2-8°C

Quality Level

Application

Midkine Inhibitor, iMDK may be used to study its anti-cancer activity on primary effusion lymphoma (PEL) in vitro.

Biochem/physiol Actions

Cell permeable: yes
Primary Target
Midkine
Reversible: yes

Disclaimer

Toxicity: Standard Handling (A)

General description

The midkine inhibitor, iMDK, demonstrates strong antiproliferative and antitumor effects both in vitro and in vivo in non-small-cell lung cancer. It also induces apoptosis of primary effusion lymphoma through G2/M cell cycle arrest.

Other Notes

Hao, H., et al. 2013. PLoS ONE8, e71093.

Packaging

Packaged under inert gas

Preparation Note

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Midkine inhibitor (iMDK) induces apoptosis of primary effusion lymphoma via G2/M cell cycle arrest
Ueno M, et al.
Leukemia Research, 116, 106826-106826 (2022)
Novel midkine inhibitor iMDK inhibits tumor growth and angiogenesis in oral squamous cell carcinoma
Masui M, et al.
Anticancer Research, 36(6), 2775-2781 (2016)

Global Trade Item Number

SKUGTIN
5.08052.000104055977242805

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service